Systemic 70% deacetylated chitin (DAC-70) as a treatment for MRL/1pr murine lupus; reduction of immunoglobulin deposition in the skin and kidneys.
Horiuchi
Y
Y
Tsurutani
R
R
Kifune
K
K
D000276:Adjuvants, Immunologic / Q000008:administration & dosage / Q000627:therapeutic use*; D000284:Administration, Oral; D000818:Animals; D002686:Chitin / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D004817:Epidermis / Q000187:drug effects / Q000276:immunology; D005260:Female; D019085:Fluorescent Antibody Technique, Direct; D007074:Immunoglobulin G / Q000187:drug effects* / Q000378:metabolism; D007668:Kidney / Q000187:drug effects* / Q000276:immunology; D007678:Kidney Glomerulus / Q000187:drug effects / Q000276:immunology; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy* / Q000276:immunology; D051379:Mice; D008815:Mice, Inbred Strains; D012867:Skin / Q000187:drug effects* / Q000276:immunology
D000276:Adjuvants, Immunologic; D007074:Immunoglobulin G; D002686:Chitin